Every year, 375+ thought leaders and influencers from industry and academia converge to showcase the latest breakthroughs in cancer immunology. Beyond the enriching discussions, the dynamic venue fosters extensive networking and collaborative opportunities, empowering teams to focus on their objectives.This summit offers a comprehensive 3-day 6-track program, exploring bi- and multispecific biotherapeutics; highlighting the latest developments in CAR T therapies, emerging targeting technologies, personalized immunotherapy, and cell-based immunotherapies; and addressing the challenges of overcoming tumor resistance. 

Thomas Trolle, Evaxion's Director of Bioinformatics & AI/ML, will present on August 7 at 8:05 AM EST, discussing computational methods for identifying targetable antigens in personalized cancer immunotherapies.

Click here to learn more about the conference